12:00 AM
 | 
May 10, 2012
 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Endocrine/metabolic disease
Diabetes CD3; insulin (INS; proinsulin); IL-10 Studies in...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >